LU91303I2 - Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP - Google Patents

Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP

Info

Publication number
LU91303I2
LU91303I2 LU91303C LU91303C LU91303I2 LU 91303 I2 LU91303 I2 LU 91303I2 LU 91303 C LU91303 C LU 91303C LU 91303 C LU91303 C LU 91303C LU 91303 I2 LU91303 I2 LU 91303I2
Authority
LU
Luxembourg
Prior art keywords
vhvt013
gallivac
hvt
ibd
pfu
Prior art date
Application number
LU91303C
Other languages
English (en)
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/823,102 external-priority patent/US5068192A/en
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of LU91303I2 publication Critical patent/LU91303I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16762—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU91303C 1986-01-27 2007-01-12 Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP LU91303I2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/823,102 US5068192A (en) 1986-01-27 1986-01-27 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
US88714086A 1986-07-17 1986-07-17
US90288786A 1986-09-02 1986-09-02
US93310786A 1986-11-20 1986-11-20

Publications (1)

Publication Number Publication Date
LU91303I2 true LU91303I2 (fr) 2007-03-12

Family

ID=27505864

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91303C LU91303I2 (fr) 1986-01-27 2007-01-12 Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP

Country Status (5)

Country Link
EP (1) EP0794257B1 (fr)
AT (2) ATE342996T1 (fr)
CA (1) CA1339468C (fr)
DE (3) DE3752389T2 (fr)
LU (1) LU91303I2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP0965639A1 (fr) * 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Pestivirus atténués
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
CN103370079B (zh) 2010-10-18 2016-08-10 英特维特国际股份有限公司 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗
WO2013057235A1 (fr) 2011-10-21 2013-04-25 Intervet International B.V. Vecteur mdv non pathogène recombinant conférant une immunité multivalente
IN2014CN02681A (fr) 2011-10-21 2015-07-03 Intervet Int Bv
US20240252624A1 (en) 2020-06-17 2024-08-01 Teshome Mebatsion Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000528A1 (fr) * 1984-07-05 1986-01-30 Genex Corporation Gene clone et son procede de preparation et d'utilisation

Also Published As

Publication number Publication date
EP0794257A1 (fr) 1997-09-10
DE122007000004I1 (de) 2007-05-24
ATE342996T1 (de) 2006-11-15
DE3752389D1 (de) 2006-11-30
ATE164885T1 (de) 1998-04-15
DE3752389T2 (de) 2007-06-14
DE3752182D1 (de) 1998-05-14
CA1339468C (fr) 1997-09-23
EP0794257B1 (fr) 2006-10-18
DE3752182T2 (de) 1998-08-06

Similar Documents

Publication Publication Date Title
PL333070A1 (en) Infectious clones of rna viruses and vaccines based on them
CA2031164A1 (fr) Herpesvirus recombinant de dindons et vaccins de vecteur vivant qui en sont derives
IL101780A0 (en) Recombinant avipox virus,the culture of cells infected with this virus and vaccines for poultry derived from this virus
ATE60799T1 (de) Virus-impfstoff.
AU3142889A (en) A recombinant marek's disease virus and a vaccine
EP0261940A3 (fr) Vaccins pseudorabiques et vecteurs d'ADN pour recombiner avec les poxvirus
EP1026246A4 (fr) Recombinants de virus herpetique infectieux aviaire et vaccins recombinants prepares avec ces derniers
ATE342996T1 (de) Attenuierte herpesviren, herpesviren die eine aminosäuresequenz kodierende fremde dna enthalten,und diese enthaltende impfstoffe
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV
DK498387D0 (da) Virus-dna-sekvens
GR3007856T3 (fr)
DE68929544D1 (de) Virale Vakzine
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
EP0774513A4 (fr) -i(HERPESVIRUS) RECOMBINE ET UTILISATION D'UN PROMOTEUR DE GENE gB
DK0623172T3 (da) Rekombinant Mareks sygdomsvirus-poxvirusvaccine
EA200100720A1 (ru) Вирусная вакцина на основе делеционного вируса герпеса крупного рогатого скота типа 1 (bhv-1)
AU8188187A (en) Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained
ATE46264T1 (de) Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis.